DelveInsight's Triple-Negative Breast Cancer Market Insights report includes a comprehensive understanding of current ...

Astellas Pharma Inc. rose the most in more than three months after quarterly profit exceeded analysts’ projections, driven by ...

A Chinese court said he had been paid to provide information on China's politics and economy to intelligence agencies.

The ruling on a Japanese businessman who was convicted earlier this month by a Chinese court for engaging in spying and sentenced t ...

As many as 19 of the top 20 publicly-traded global biopharma companies reported revenue growth in 2024, with an overall 7.9% ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Review quarterly and annual revenue, net income, and cash flow for Astellas Pharma Inc (ALPMF:PINX) stock through the last fiscal year.

In July 2025, Novartis Pharmaceuticals organized a study is to assess the effect of Iptacopan to prevent conversion of early ...

Japan's Nikkei share average gained on Thursday as the Bank of Japan kept interest rates steady as was widely expected, while ...

The Nikkei was up 0.9% at 41,015.31, as of 0351 GMT. The broader Topix traded 0.7% higher. Investor focus now turns to BOJ Governor Kazuo Ueda's press conference at 0630 GMT for hints on the timing of ...

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...

A Financial Times analysis of dozens of sales contracts and company filings and interviews with multiple people with direct ...